Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bonacia / 博纳西亚

Explore full profile

China Phase I–IV clinical CRO for chem / biologic / vaccine

ChinaFounded 2004Biotech & Life Sciences
Valuation $50–100M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Bonacia / 博纳西亚 and the history behind them.

About Bonacia / 博纳西亚

China clinical CRO (Bonacia / 博纳西亚; Panacro) — Phase I–IV clinical operations, biostats/DM, QA and vaccine-trial adjacency for chemical / biologic / vaccine sponsors with US twin path and national 20-province office footprint. 博纳西亚医药科技 founded 2004; mid-size China clinical-CRO leftover beyond Pack 36 Highthink·R&G FIX / Mon ClinChoice·Boji·SUNNOVO DNR / Tigermed mega soft-skip.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2004
Headquarters
China
Employees
34
Open positions
None listed
Dealroom signal
51.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Vaccines, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology
Artificial Intelligence
Business model
Manufacturing
Client focus
b2b
Links
WebsiteLinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Dec 2023 $14M $55M Jinhe Capital · Shenzhen Cornerstone Asset Management ↗
SERIES A✓Equity / VC Apr 2022 $0 — Xintaige Assets · Topsailing Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Bonacia / 博纳西亚 website traffic

Latest recorded traffic for Bonacia / 博纳西亚 is 110 monthly website visits, down 85.9% over the last three months. Bonacia / 博纳西亚's team grew 6.3% over the past year.

Latest monthly visits110 3-month web change-85.9% 1-year team growth+6.3%
Monthly website visitsDec 2023–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
DeepflareDeepflare is an AI company helping pharma firms accelerate cancer vaccine and immunotherapy development Warsaw, Poland Operational 6 $1.6M $6.6M
Ab&B BiotechFocuses on the research and development of innovative human vaccines and multivalent vaccines Taizhou, China Operational
ZeaVaxxDeveloping a plant-derived nanoparticle that can improve animal vaccines West Lafayette, United States Operational
Normax BiomedNormax focus for 2022 is rapid growth in mRNA Vaccine R&D and manufacturing for sustainable pandemic preparedness Cork, Ireland Operational
CHA Vaccine InstituteTea vaccine research is a state-of-the-art biotech company developing vaccines and immunotherapys South Korea Operational
RVAC MedicinesMRNA platform company engaged in the research and development of innovative products such as vaccines for diseases Singapore Operational
Curevo VaccineCreating Next Generation Vaccines For Diseases Of Global Importance Seattle, United States Acquired
PhageNova BioPioneering Targeted Gene Expression For Cancer and Vaccines Summit, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Yida Capital

Series A4 investors entered at this stage

  • Xintaige Assets
  • Topsailing Capital
  • Jinhe Capital
  • Shenzhen Cornerstone Asset Management

Talent

Book a demo to see the people
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Bonacia / 博纳西亚 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bonacia / 博纳西亚’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.